الفهرس 
PRETERM BIRTHOnly 14 pages are availabe for public view
 |  | from | 139 |  |  |
| | | from | 139 | | |
Abstract
Background: Preterm birth is known to be the birth before 37 weeks of gestation. The incidence of preterm birth is in increase over the recent years. It is affecting about 12 % of births in the United States and also responsible for 2/3 of neonatal mortality. Although there is improvement in the neonatal care, the preterm birth is considered the main cause of long term disabilities in children born without congenital anomalies. Thus the prevention of preterm birth is the target of obstetric care.
Aim of the Work: to evaluate the effect of prophylactic vaginal progesterone on reducing the incidence of preterm birth and neonatal morbidity or mortality.
Patients and Methods: This is a prospective double blind, randomized, placebo-controlled trial. This research included women who had an arrested preterm birth episode using tocolysis and we will give them vaginal progesterone 200 µg as a prophylactic treatment to preterm birth and to evaluate its efficacy on prolonging pregnancy.
Results: This study shows a positive correlation between using of vaginal progesterone suppositories (200mg) and decreasing the risk of preterm birth after the arrest of episode of preterm birth using tocolysis.
Conclusion: Pregnant women should be encouraged to use vaginal progesterone as a prophylactic treatment after the arrest of preterm birth.